CION Cancer Clinics
Maintenance therapy after myeloma treatment | CION Cancer Clinics
Maintenance is a gentler, long-term treatment given after the main myeloma treatment to keep the disease quiet for longer. Lenalidomide capsules are the usual choice, started a few months after a stem cell transplant once counts recover. It means fewer visits and no steroid, but it still needs regular blood tests. How long it lasts depends on your myeloma, side effects and your wishes. At CION Cancer Clinics, our haematology team plans myeloma and lymphoma care with you, discussed at a tumour board and explained in plain words.
On this page
- What is maintenance therapy for myeloma?
- How does maintenance usually begin?
- Which side effects matter most during maintenance?
- What helps maintenance go smoothly?
- What do families often misunderstand about maintenance?
- How long does it last, and what can this page not tell you?
- Common questions about lenalidomide maintenance
The short answer
What is maintenance therapy for myeloma?
Maintenance is a lower-intensity treatment taken for a long time after the main treatment, to keep myeloma quiet for longer. Lenalidomide capsules are the most common choice, usually started a few months after a stem cell transplant.
Why keep treating when the report looks good
After induction and a transplant, blood tests may show very little myeloma left. A small number of myeloma cells usually remain, even when tests cannot find them. Maintenance keeps pressure on those cells. For most people it lengthens the time before the myeloma returns, which is why it is a standard part of the plan.
What it feels like compared with induction
Maintenance is gentler. There is usually no steroid, fewer clinic visits and a lower dose. Most people go back to work, travel and family life. It is still an anti-cancer medicine, though, and it still needs blood tests and attention to side effects.
When lenalidomide is not the choice
If the myeloma has high-risk genetic features, the team may add or prefer bortezomib, or use daratumumab. If lenalidomide caused serious problems during induction, another option may be used. People who did not have a transplant may continue a lighter version of their first combination instead of a separate maintenance phase.
What it asks of the family
Because maintenance runs for a long time, the routine becomes the family's routine. Someone needs to know the capsule calendar, the blood test dates and what a fever means. It helps to agree early who will collect the capsules, who will go to reviews, and who will keep the reports in one folder.
This page gives no doses. Your haematologist sets the dose and schedule, and adjusts them over time.Getting started
How does maintenance usually begin?
Recovery first
After a transplant, the blood counts need time to recover and infections need to settle. Maintenance usually waits until the team is satisfied that your body is ready.
Baseline tests
Blood counts, kidney tests and the myeloma markers are checked, so later results have something to be compared with. Pregnancy rules and clot prevention are reviewed again.
The first cycles
Capsules are taken at home on set days. Blood counts are checked more often at the start, because this is when drops in white cells or platelets tend to show up.
Settling into a routine
Once things are stable, visits space out. Most people have a blood test and a review at regular intervals, with the myeloma markers checked along the way. Keep every result in one folder, so any doctor you see can compare the trend at a glance.
Not sure whether this applies to you?
Ask an oncologistWhat to watch for
Which side effects matter most during maintenance?
Most people manage well. These are the problems worth knowing about and reporting early.
Low blood counts
White cells and platelets can drop, especially early on. That raises the chance of infection and bruising. Fever needs a same-day call, even if you feel otherwise well.
Loose motions
This can build slowly over months and is easy to put down to diet. It is common with long-term lenalidomide and there are ways to manage it, so mention it.
Tiredness and muscle cramps
Mild tiredness is common. Cramps, often at night, are also reported. Tell the team if either stops you living normally.
Blood clots
The risk is lower than during induction but not zero. A swollen, painful calf or sudden breathlessness needs urgent care.
A second cancer
Long-term lenalidomide after a transplant slightly raises the chance of another cancer later. Doctors weigh this against the benefit of keeping myeloma controlled, and keep up routine screening.
A fever or shivering, a swollen and painful calf on one side, sudden breathlessness or chest pain, or bleeding that will not stop needs care the same day. Go to the nearest emergency department or call 108, and say the person is on lenalidomide for myeloma. Take the medicine pack or calendar with you.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
At home
What helps maintenance go smoothly?
- A written calendar of capsule days and rest days
- A thermometer at home, and a clear plan for fever
- Capsules stored safely, away from children and pregnant women
- Blood tests kept on schedule, even when you feel well
- Vaccines reviewed with the team after a transplant
- A list of all medicines to show any other doctor
Commonly believed
What do families often misunderstand about maintenance?
Maintenance is part of the plan, not an add-on. Its purpose is to keep the good result from the transplant going for longer. Talk to the team before making any change to it.
Normal markers are very good news, and they are what maintenance aims to protect. Very small amounts of myeloma can remain below what standard tests detect. That is why follow-up continues.
Counts can still fall on a lower dose, especially in the first months. The tests are how the team keeps the dose safe for you. Skipping them makes the treatment riskier, not easier.
Many people take it for a long time, but it is reviewed regularly. It may be stopped or changed because of side effects, a change in the myeloma or after a long stable period. The decision is made with you.
Being straight with you
How long does it last, and what can this page not tell you?
There is no single answer. Practice differs between teams and countries. Some continue lenalidomide for as long as it keeps myeloma controlled and is tolerated. Others review after a set period of stable results.
What shapes the length for you
The genetic features of the myeloma, how deep the response was after transplant, side effects, second-cancer risk, cost and your own wishes all play a part. A regular conversation about whether to continue is normal, and it is fine to raise it yourself.
What the markers can and cannot tell you
A rising M-protein or light chain level on repeat tests may be an early sign the myeloma is returning. A single change is not a verdict. The team looks at the trend over several tests before changing treatment.
Who to call
At CION, the haematology team reviews maintenance results and presents any change in plan at a tumour board. If you had your transplant elsewhere, bring the discharge summary and the transplant centre's maintenance advice to your first visit.
Questions we are asked
Common questions about lenalidomide maintenance
When does maintenance start after a transplant?
Usually a few months after the transplant, once blood counts have recovered and any infections have settled. The exact timing depends on how your recovery goes. Your transplant centre and haematologist agree the start together, so ask them for the planned date at your discharge visit.
Can I work and travel while on maintenance?
Most people do. Plan travel around blood test dates, carry enough capsules in their original pack, and keep a note of the helpline number. Before a long trip, ask the team about infection precautions and what to do if a fever starts far from home.
What if I miss a capsule?
Do not take two to make up for it. Follow the instructions on your own prescription leaflet, and call the team if you are unsure. Note the missed day on your calendar and mention it at the next visit, especially if it keeps happening.
Is maintenance used if there was no transplant?
People who do not have a transplant often stay on a continuous combination such as DRd. Over time the team may lower the intensity, which works in a similar way to maintenance. The name differs, but the aim of keeping myeloma controlled is the same.
Why am I being given bortezomib instead of lenalidomide?
Bortezomib, alone or with lenalidomide, is sometimes preferred when the myeloma has high-risk genetic features or when kidney function is poor. Your haematologist chose it for a reason specific to you. Ask them to explain which feature of your report led to that choice.
Can I have vaccines during maintenance?
Inactivated vaccines are usually recommended, and after a transplant many childhood vaccines need to be given again. Live vaccines need special care and are often avoided. Ask the team for a written vaccine schedule rather than arranging vaccines elsewhere on your own.
Does maintenance stop the myeloma coming back?
It usually delays the return, but myeloma tends to come back at some point in most people. When it does, there are several further treatment options. Regular marker tests help the team spot a return early, often before you notice any symptoms.
Is lenalidomide maintenance covered by schemes?
Coverage depends on the scheme and its current rules, which change. Aarogyasri, PM-JAY, CGHS, ECHS, EHS and cashless insurance may each cover parts of long-term treatment. Bring your card and policy details, and ask the team to check coverage before maintenance begins.
Meet CION's haematologist. One specialist for your blood report and your plan.
Dr. Basudev Pokhrel reviews blood counts, transfusion needs and blood disorders, and works with the CION tumour board on blood cancers.
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- National Cancer Institute — Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ), Patient Version
- Macmillan Cancer Support — Myeloma
- NICE — Myeloma: diagnosis and management (NG35)
- American Cancer Society — Multiple Myeloma
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Starting or reviewing maintenance treatment?
Share the transplant summary and recent reports. CION's haematology team will review the plan with you and explain the next step.